| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 13.59B | 12.75B | 13.07B | 12.56B | 11.57B | 9.95B |
| Gross Profit | 7.83B | 7.35B | 7.36B | 6.84B | 6.45B | 5.62B |
| EBITDA | 1.52B | 1.38B | 1.08B | 1.19B | 1.62B | 1.39B |
| Net Income | 940.39M | 830.89M | 734.90M | 560.63M | 1.05B | 912.45M |
Balance Sheet | ||||||
| Total Assets | 12.15B | 11.87B | 11.20B | 10.18B | 10.06B | 8.71B |
| Cash, Cash Equivalents and Short-Term Investments | 3.92B | 4.23B | 3.13B | 2.62B | 2.82B | 1.42B |
| Total Debt | 1.91B | 1.98B | 1.76B | 2.05B | 2.15B | 2.01B |
| Total Liabilities | 4.22B | 3.93B | 3.96B | 3.51B | 3.91B | 3.60B |
| Stockholders Equity | 7.94B | 7.94B | 7.25B | 6.67B | 6.16B | 5.11B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.18B | 934.18M | 84.17M | 1.36B | 524.27M |
| Operating Cash Flow | 0.00 | 1.21B | 964.32M | 315.56M | 1.41B | 546.91M |
| Investing Cash Flow | 0.00 | -102.41M | 10.99M | -361.40M | -94.15M | -88.92M |
| Financing Cash Flow | 0.00 | -9.58M | -465.46M | -156.67M | 93.74M | -207.58M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥18.54B | 13.52 | ― | 3.53% | 5.03% | -9.55% | |
73 Outperform | ¥11.67B | 9.43 | ― | 2.10% | 13.64% | 44.55% | |
66 Neutral | ¥21.85B | 23.11 | ― | ― | 30.15% | 31.28% | |
62 Neutral | ¥3.19B | 5.37 | ― | ― | -3.76% | -67.98% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
59 Neutral | ¥12.60B | 37.44 | ― | 1.01% | 17.19% | -43.91% | |
45 Neutral | ¥3.43B | -275.17 | ― | ― | 4.84% | -54.50% |